Brokerages Set Aurora Cannabis Inc. (NYSE:ACB) Target Price at $2.07

Aurora Cannabis Inc. (NYSE:ACB – Get Rating) has received a consensus recommendation of “Hold” from the seven research firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $2.07.

A number of equities analysts have recently weighed in on ACB shares. Piper Sandler reduced their price target on shares of Aurora Cannabis from $2.00 to $1.00 in a research report on Wednesday, December 28th. Stifel Nicolaus reduced their price target on shares of Aurora Cannabis from C$1.75 to C$1.45 in a research report on Friday, January 27th.

Institutional Investors Weigh In On Aurora Cannabis

Institutional investors have recently added to or reduced their stakes in the stock. Advisor Group Holdings Inc. increased its stake in Aurora Cannabis by 9.7% in the 1st quarter. Advisor Group Holdings Inc. now owns 61,873 shares of the company’s stock valued at $309,000 after buying an additional 5,488 shares during the last quarter. Royal Bank of Canada increased its stake in Aurora Cannabis by 9.5% in the 3rd quarter. Royal Bank of Canada now owns 115,794 shares of the company’s stock valued at $141,000 after buying an additional 10,000 shares during the last quarter. Foundations Investment Advisors LLC increased its stake in Aurora Cannabis by 16.8% in the 3rd quarter. Foundations Investment Advisors LLC now owns 75,018 shares of the company’s stock valued at $92,000 after buying an additional 10,798 shares during the last quarter. Citigroup Inc. increased its stake in Aurora Cannabis by 566.4% in the 1st quarter. Citigroup Inc. now owns 14,334 shares of the company’s stock valued at $57,000 after buying an additional 12,183 shares during the last quarter. Finally, HighTower Advisors LLC acquired a new stake in Aurora Cannabis in the 1st quarter valued at $50,000. 13.97% of the stock is owned by institutional investors.

Aurora Cannabis Price Performance

ACB opened at $1.06 on Friday. The company has a fifty day moving average price of $1.03 and a two-hundred day moving average price of $1.27. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.19 and a current ratio of 4.07. Aurora Cannabis has a 52 week low of $0.82 and a 52 week high of $4.90. The firm has a market capitalization of $343.79 million, a PE ratio of -0.17 and a beta of 2.58.

Aurora Cannabis (NYSE:ACB – Get Rating) last released its earnings results on Thursday, November 10th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01. Aurora Cannabis had a negative net margin of 838.11% and a negative return on equity of 46.40%. The firm had revenue of $37.77 million during the quarter, compared to analyst estimates of $38.85 million. As a group, analysts anticipate that Aurora Cannabis will post -0.34 earnings per share for the current year.

About Aurora Cannabis

(Get Rating)

Aurora Cannabis, Inc engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.